Andrew Turitz - Mar 3, 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
SVP - CORPORATE DEVELOPMENT
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Mar 3, 2023
Transactions value $
-$46,510
Form type
4
Date filed
3/7/2023, 03:11 PM
Previous filing
Mar 3, 2023
Next filing
Jun 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Sale -$46.5K -1.8K -7.3% $25.91 22.8K Mar 3, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Award $0 +37.2K $0.00 37.2K Mar 3, 2023 Common Stock 37.2K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards.
F2 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F3 One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.